IBDoc® offers an easy and intuitive solution to measure and track the inflammation in patients suffering from Inflammatory Bowel Disease (IBD) such as ulcerative colitis and Crohn’s Disease.

As part of the IBDoc® calprotectin home test, CalApp® allows measuring the calprotectin concentration in a stool sample using a smartphone. The app contains an easy to understand tutorial explaining the test procedure step by step from the collection of the stool sample to sample extraction and loading of the pregnancy test-like test cassette. Once the test cassette is prepared, the CalApp® controls the mobile device camera to take a picture of the test cassette. The optical signal of the test is analyzed with the help of a specific barcode on the test cassette. The signal is translated into a result that indicates the calprotectin concentration in the stool sample.
The test information is managed on the smartphone itself and at the same time transmitted via a secure and encrypted connection to the IBDoc® Portal. The test results and connected patient information are stored securely on the IBDoc® Portal and can only be accessed by both the patient and his responsible health care professional.

The CalApp® features include:

-tutorial with schematic drawings and text explaining the test procedure step by step

-A list of all test results performed on the device

-help menu with a tutorial video and support contact

Please be aware that the CalApp® only works with an IBDoc® Account and an IBDoc® test kit. This Account has to be set up by a health care professional. Please contact your IBD doctor or IBD clinic for additional information.

Please read the Instruction for Use included in the IBDoc® test kit carefully before performing the first test.

CalApp® has been validated for specific smartphone models to ensure accurate results, please consult the list of validated smartphones here: www.ibdoc.net/support

A data connection is required. Depending on your carrier additional costs might arise.

BÜHLMANN Laboratories AG declares that the CalApp® software meets the essential health and safety requirements of EC Directive on in vitro diagnostic medical devices 98/79/EC and the Canadian Medical Devices Regulations SOR/98-282, and is in conformity with the relevant sections of applicable harmonized standards and other normative documents.

CE-marked product: CE0123

BÜHLMANN IBDoc® is not available for sale in the US.

IBDoc® and CalApp® are registered trademarks of BUHLMANN Laboratories AG in many countries.
Read more
25 total

What's New

Bug Fixes
Read more

Additional Information

December 2, 2019
Current Version
Requires Android
4.0.3 and up
Content Rating
Offered By
BÜHLMANN Laboratories AG
BÜHLMANN Laboratories AG Baselstrasse 55 CH-4124 Schönenbuch Switzerland
©2020 GoogleSite Terms of ServicePrivacyDevelopersAbout Google|Location: United StatesLanguage: English (United States)
By purchasing this item, you are transacting with Google Payments and agreeing to the Google Payments Terms of Service and Privacy Notice.